Why We Aren’t Seeing Many Big Cannabis Deals With Other Industries

Cannabis is still very polarizing for consumers and investors. While it presents a great opportunity, with it being a brand-new industry to get involved in, it also presents a risk, particularly for established companies. Branding is important, and if a company gets it wrong, it could risk alienating its existing consumers, which would be bad news for its stock. Warren…

Read More

Another Cannabis Company to Enter the U.S. Market (Hint: It’s Not Aurora)

As states in the U.S. continue to legalize recreational marijuana, the opportunity for that market continues to expand. And while Canopy Growth has already made moves to tap into that market, rival Aurora Cannabis Inc  (TSX:ACB)(NYSE:ACB) has remained idle. Although Aurora is likely sizing up investment opportunities and it has added some key personnel into the mix to help on that…

Read More

1 Cannabis Stock You Should Buy Now and 1 You Need to Sell

It’s time to start getting picky about pot stocks. The dust certainly hasn’t settled yet, though there has been a bit of mellowing out around the marijuana sector. After record highs came some lows, and now investors need to start getting serious about where certain stocks are headed. Hopefully, it’s in an upward direction. But that means these stocks have…

Read More

Hexo (TSX:HEXO) Stock Is up 123% Year to Date: Is This Sustainable?

$2.1 billion Hexo (TSX:HEXO) can be classified as one of the many cannabis companies that are flying high in a race to capture as much of the multi-billion cannabis market as possible. With a product offering including pre-rolls, flower, oil, and decarb products, the company has 1.8 million square feet of facilities in Ontario and Quebec and is working hard…

Read More

A Half-Year After Legalization: Canopy Growth (TSX:WEED) vs. Aurora Cannabis (TSX:ACB)

The end of April marks over six months since Canada officially legalized recreational cannabis. It has not been the most efficient roll-out across the provinces, but production at the top producers is starting the ramp up. By the end of 2019, supply issues should be largely resolved. Now investors can worry about growth at the top companies. The sector has…

Read More

Why the U.S. Market Stands to Be a Massive Catalyst for Cannabis Stocks

In December, the United States Congress agreed to pass into motion the Agriculture Improvement Act of 2018, otherwise known as “The Farm Bill.” Among other initiatives, the Farm Bill reintroduced legislation to legalize commercial hemp production for the first time since 1937. And while Cannabidiol or CBD, currently remains a Schedule 1 drug, the new Farm bill does open the…

Read More

PURA Credits Kali-Extracts (USOTC: KALY) Instrumental Role In Cannabis Beverage Sales Growth

Kali Extracts

DALLAS, April 24, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Puration, Inc. (USOTC: PURA) (“PURA”) today issued a statement crediting Kali-Extracts (USOTC: KALY) role in PURA’s cannabis beverage sales growth to date and going forward. PURA yesterday released a management presentation offering detail and insight into the company’s recently published 2018 financial statement and plans for ongoing growth…

Read More

Navigating Our Way Around Cannabis Stocks: Should We Buy Now?

Cannabis stocks continue to roar on, as the cannabis industry continues to move forward and make good on its promise of high growth. But returns and profits are a different story, and we are still waiting to see which companies will be the ultimate winners. Let’s take a look at three of the biggest cannabis companies, some latest developments, and…

Read More

Cannabis Investors: Here’s a Great New Way to Take Advantage of a Soaring U.S. Market

As strong as the cannabis industry is today, the better opportunity for investors may very well be in the U.S. markets. With 10 states having legalized marijuana and more on likely on the way, it has proven to be a very hot industry. While a stock like Aurora Cannabis (TSX:ACB)(NYSE:ACB) has done very well for itself, rising more than 75% since…

Read More

Aphria Inc. (TSX:APHA) Disappoints: Is the Stock Price Attractive Today?

I have long written about the problem with cannabis stocks and their valuations and the expectations that are built into them. I’ve also written about the strong likelihood that higher-than-expected spending, shareholder dilution, and slower-than-expected revenue growth will likely be very detrimental to stock prices. The industry, cycle, and growth are in their early stages. Aphria (TSX:APHA)(NYSE:APHA) reported its third-quarter…

Read More